Parkinson
Beyond's analysis on Parkinson
Recent news mentioning Parkinson
- — Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026
- — Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026
- — Arvinas to Present Novel Biomarker Data from the Phase 1 Clinical Trial for ARV-102, a PROTAC LRRK2 Degrader, at the 2026 International Congress of Parkinson’s Disease and Movement Disorders®
- — Angels on Call Homecare Achieves Second Re-Accreditation, Reinforcing National Leadership in Specialized Parkinson's Care
- — Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)
- — Gain Therapeutics Announces Poster Presentation at International Congress of Parkinson’s Disease and Movement Disorders
- — U.S. FDA Approves AbbVie's JUVMO™ (tavapadon) for Parkinson's Disease
- — Revealed: the undisclosed safety data emerging as weedkiller maker faces Parkinson’s lawsuits in US
- — Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress"
- — Lunai Bioworks (NASDAQ: LNAI) Expands Parkinson's Platform Through Exclusive Tanaist Agreement
- — Parkinson's Foundation Requests Applications for Second Annual "Paul Oreffice Innovations in Care Awards"
- — Michael J. Fox Foundation Announces $2.5 Billion "All Grit. No Quit." Campaign to Accelerate Parkinson's Breakthroughs